Cent Eur J Public Health 2014, 22(Supplement):S75-S80

Clinical and Biochemical Determinants of Metabolic Syndrome among Roma and Non-Roma Subjects in the Eastern Part of Slovakia

Ján Fedačko1, Daniel Pella1, Peter Jarčuška1, Leonard Siegfried2, Martin Janičko1, Eduard Veselíny1, František Sabol3, Pavol Jarčuška4, Mária Mareková5, Andrea Madarasová Gecková6,12, Peter Pažinka7, Monika Jankajová8, Ján Kmec9, Marián Babčák9, Peter Kalanin10, Sylvia Dražilová11
1 1st Department of Internal Medicine, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
2 Department of Medical Microbiology, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
3 Department of Cardiosurgery, Eastern Slovak Cardiovascular Institute, Košice, Slovakia
4 Department of Infectious Diseases, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
5 Department of Medical Biochemistry, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
6 Olomouc University Social Health Institute, Palacký University in Olomouc, Olomouc, Czech Republic
7 1st Department of General Surgery, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
8 Department of Cardiology, Eastern Slovak Cardiovascular Institute, Košice, Slovakia
9 Department of Cardiology and General Internal Medicine, J. A. Reiman Hospital, Prešov, Slovakia
10 Department of Family Medicine, P. J. Šafárik University in Košice, Faculty of Medicine and L. Pasteur University Hospital, Košice, Slovakia
11 Department of Internal Medicine, Poprad Hospital, Poprad, Slovakia
12 Health Psychology Unit, Department of Public Health, Faculty of Medicine, P. J. Šafárik University in Košice, Košice, Slovakia

Background: The metabolic syndrome (MS) is a clustering of cardiovascular risk. The high prevalence of metabolic syndrome among populations of lower socioeconomic status is a cause of concern and calls for an effective public health response.

Objectives: The aim of this study was to determine the prevalence of metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia and to determine the parameter which has the strongest association with metabolic syndrome.

Results: 123 Roma and 79 non-Roma patients with metabolic syndrome were evaluated. In the subgroup of Roma men, we found that waist circumference conferred the highest chance of MS (more than 12-times), followed by triglycerides (TG) (3.670-times). In the subgroup of non-Roma men, we found that waist circumference conferred the highest chance of MS (more than 16-times), followed by high-density lipoprotein (HDL) (4.348-times increased risk per one unit decrease in HDL). In the subgroup of Roma women as well as non-Roma women, we found that serum TG conferred the highest chance of MS, followed by waist circumference for Roma women. Comparing non-classical risk factors for MS we found that only age (with OR 1.977) and high-sensitivity C-reactive protein (hsCRP) (OR 1.887) were significant and independent predictors of MS in Roma men. Among Roma women apolipoprotein B100 was also found to be an independent predictor of MS, besides age and hsCRP.

Conclusion: Our study confirmed that the prevalence of metabolic syndrome is strongly associated with hypertriglyceridemic waist, besides other risk factors, a marker of the atherogenic metabolic triad among younger Roma population, which may be the reason for the increased cardiovascular (CV) morbidity and mortality in elderly Roma compared with non-Roma. In light of these results, better prevention of CV events for Roma minority settlements in Slovakia should be provided.

Klíčová slova: metabolic syndrome, Roma population, laboratory biomarkers, cardiovascular risk factors, obesity

Zveřejněno: 1. březen 2014  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fedačko J, Pella D, Jarčuška P, Siegfried L, Janičko M, Veselíny E, et al.. Clinical and Biochemical Determinants of Metabolic Syndrome among Roma and Non-Roma Subjects in the Eastern Part of Slovakia. Cent Eur J Public Health. 2014;22(Supplement):S75-80. PubMed PMID: 24847619.
Stáhnout citaci

Reference

  1. Kannel WB, Cupples LA, Ramaswami R, Stokes J 3rd, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol. 1991;44(2):183-90. Přejít k původnímu zdroji...
  2. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001 Apr;24(4):683-9. Přejít k původnímu zdroji...
  3. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003 May;52(5):1210-4. Přejít k původnímu zdroji... Přejít na PubMed...
  4. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004 Sep 7;110(10):1251-7. Přejít k původnímu zdroji... Přejít na PubMed...
  5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002 Dec 4;288(21):270916. Přejít k původnímu zdroji...
  6. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA; American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004 Feb 3;109(4):551-6. Přejít k původnímu zdroji... Přejít na PubMed...
  7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. Přejít k původnímu zdroji...
  8. Baker D, Mead N, Campbell S. Inequalities in morbidity and consulting behaviour for socially vulnerable groups. Br J Gen Pract. 2002 Feb;52(475):124-30.
  9. Cappuccio FP. Ethnicity and cardiovascular risk: variations in people of African ancestry and South Asian origin. J Hum Hypertens. 1997 Sep;11(9):571-6. Přejít k původnímu zdroji... Přejít na PubMed...
  10. Krcho P, Bazárová J, Diheneščíková D. Composition of the mother milk during the first five days in low and high risk population.Acta Med Port. 2012;25 Suppl 2:163.
  11. Ginter E, Krajcovicova-Kudlackova M, Kacala O, Kovacic V, Valachovicova M. Health status of Romanies (Gypsies) in the Slovak Republic and in the neighbouring countries. Bratisl Lek Listy. 2001;102(10):479-84. Přejít na PubMed...
  12. Dolinska S, Kudlackova M, Ginter E. The prevalence of female obesity in the world and in the Slovak Gypsy women. Bratisl Lek Listy. 2007;108(45):207-11. Přejít na PubMed...
  13. Sinha S, Misra P, Kant S, Krishnan A, Nongkynrih B, Vikram NK. Prevalence of metabolic syndrome and its selected determinants among urban adult women in South Delhi, India. Postgrad Med J. 2013 Feb;89(1048):68-72. Přejít k původnímu zdroji... Přejít na PubMed...
  14. Koupilová I, Epstein H, Holčík J, Hajioff S, McKee M. Health needs of the Roma population in the Czech and Slovak Republics. Soc Sci Med. 2001 Nov;53(9):1191-204. Přejít k původnímu zdroji...
  15. Madarasová Gecková A, Jarčuška P, Mareková M, Pella D, Siegfried L, Jarčuška P, et al.; HepaMeta Team. HepaMeta - Prevalence of hepatitis B/C and metabolic syndrome in population living in separated and segregated Roma settlements: a methodology for a cross-sectional populationbased study using community-based approach. Cent Eur J Public Health. 2014 Mar;22 Suppl:S6-11. Přejít k původnímu zdroji...
  16. Vozarova de Courten B, de Courten M, Hanson RL, Zahorakova A, Egyenes HP, Tataranni PA, et al. Higher prevalence of type 2 diabetes, metabolic syndrome and cardiovascular diseases in gypsies than in nongypsies in Slovakia. Diabetes Res Clin Pract. 2003 Nov;62(2):95-103. Přejít k původnímu zdroji...
  17. Lemieux I, Pascot A, Almeras, N. Obesity in the 21(st) century: new approaches? Ann Endocrinol (Paris). 2001;62(4):255-61.
  18. Després JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001 Mar 24;322(7288):716-20. Přejít k původnímu zdroji... Přejít na PubMed...
  19. Ostrihoňová T, Bérešová J. Occurrence of metabolic syndrome and its risk factors amongst a selected group of Roma inhabitants. Hygiena 2010;55(1):7-14. (In Slovak.)
  20. Lanaspa MA, Sautin YY, Ejaz AA, Madero M, Le MP, Manitius J, et al. Uric acid and metabolic syndrome: what is the relationship? Curr Rheumatol Rev. 2011;7(2):162-9. Přejít k původnímu zdroji...
  21. Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013 Mar;25(2):210-6. Přejít k původnímu zdroji... Přejít na PubMed...
  22. Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):961-7. Přejít k původnímu zdroji... Přejít na PubMed...